SCHEMBL21710707

SCHEMBL21710707

c1ccc2c(c1)ccc1c2c2cc(-n3c4ccccc4c4ccccc43)cc3c4ccccc4n1c32

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 4/20 0.32
HSD17B10 Q99714 3/20 0.32
HIF1A Q16665 2/20 0.32
CYP1B1 Q16678 1/20 0.32
TSHR P16473 2/20 0.31
CYP2A6 P11509 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
NQO2 P16083 2/20 0.31
CYP1A2 P05177 2/20 0.30
FYN P06241 2/20 0.30
ACHE P22303 2/20 0.30
AHR P35869 2/20 0.30
HPGD P15428 2/20 0.30
ERBB2 P04626 1/20 0.30
MAOA P21397 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21717395 0.87 KDM4E (0.38) ATML3MBTL1KDM4EALDH1A1TDP1
SCHEMBL25965130 0.86 L3MBTL1 (0.44) ATML3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL17146739 0.84 KDM4E (0.56) ATML3MBTL1KDM4EALDH1A1CYP1A2
SCHEMBL21718131 0.84 CYP2A6 (0.40) ATML3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL18502690 0.83 MEN1 (0.39) ATML3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL21710705 0.82 PTGES (0.36) KDM4EALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL25638804 0.82 KDM4E (0.54) ATML3MBTL1KDM4EALDH1A1CYP1A2
SCHEMBL21710474 0.81 PTGES (0.35) KDM4EALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL21710472 0.81 PTGES (0.38) KDM4EALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL18502565 0.81 MEN1 (0.37) ATML3MBTL1KDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20200365812-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-11-19 US disclosed
US-20200052212-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE LEF1, L1CAM, ESR2 ATM 3221/4885L3MBTL1 683/4885KDM4E 2210/4885
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE OR51E2, CD99, CTNND1 ATM 2817/4885L3MBTL1 1709/4885KDM4E 2086/4885
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS EML4, EBPL, LEF1 ATM 3672/4885L3MBTL1 721/4885KDM4E 2270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.